Cerebrolysin IV Therapy Now Available at NexGen Health in Silicon Valley
NexGen Health in
Designed to aid patients with stroke, traumatic brain injury, cognitive decline, and neurodegenerative diseases, this science-backed therapy enhances neuroplasticity, reduces inflammation, and supports long-term brain health.
Led by board-certified physicians specializing in regenerative medicine, physical medicine, interventional pain, and functional medicine, NexGen Health's Cerebrolysin program is centered around a personalized 10-treatment intravenous protocol. Patients are carefully evaluated and monitored throughout the process, which is designed to support recovery from stroke, traumatic brain injury, cognitive decline, and neurodegenerative diseases such as Alzheimer's and Parkinson's.
"We are thrilled to bring this groundbreaking neurorecovery therapy to
Cerebrolysin is a neuropeptide-based therapy containing small proteins and amino acids that mimic naturally occurring neurotrophic factors—the compounds that support neuron growth and survival. Unlike many therapies, Cerebrolysin is capable of crossing the blood-brain barrier, enabling direct access to brain tissue. Its clinical effects include stimulation of neuroplasticity, reduction of neuroinflammation, improved synaptic function, and protection against oxidative stress.
Each treatment begins with medical clearance through NexGen Health's clinical team. Once approved, patients receive daily or alternate-day IV infusions of Cerebrolysin over a 10-day period, with treatment sessions typically lasting 20 to 45 minutes. The peptides are rapidly absorbed and transported to brain tissue, where they deliver neuroprotective and regenerative effects through a variety of scientifically validated pathways.
The protocol is tailored to patient-specific goals and may be repeated or adjusted based on progress. Many patients report encouraging outcomes within the first cycle, with ongoing improvements in cognitive clarity, focus, motor function, and neurologic resilience.
"What sets our Cerebrolysin program apart is our comprehensive, physician-supervised approach," said Dr.
With this launch, NexGen Health further strengthens its position as a leader in innovative biologic and regenerative treatments. The clinic recently introduced Niagen Plus IV Therapy and celebrated a major milestone of 150 five-star Google reviews, underscoring its reputation for patient satisfaction, safety, and results-driven care.
Located in the heart of
About NexGen Health
Founded by Dr.
To learn more about the Cerebrolysin IV Therapy Program or to schedule a consultation, visit www.MyNexGenHealth.com or call (408) 400-2967.
Medical clearance through NexGen Health's medical team is required to begin treatment.
Media Contact:
Ilbra Petros
Director, NexGen Health
Phone: (408) 400-2967
Website: www.MyNexGenHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cerebrolysin-iv-therapy-now-available-at-nexgen-health-in-silicon-valley-302553961.html
SOURCE NexGen Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland County Garage Doors Provides Professional Garage Door Solutions for Lawndale, NC Homeowners and Businesses
- UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million
- Direct Reach Expands U.S. Education Audience Data
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share